“Adoption of Antimicrobial-Integrated Wound Dressings”
- A significant trend in the wound dressings market is the increasing use of antimicrobial-integrated dressings to prevent infections and accelerate healing, particularly in chronic and surgical wounds. These dressings help reduce the need for systemic antibiotics, lowering antimicrobial resistance risks
- Healthcare professionals are favoring silver, iodine, and honey-based dressings for their broad-spectrum antimicrobial properties, especially in treating diabetic foot ulcers and pressure sores
- The adoption of such dressings is aligned with the global effort to curb hospital-acquired infections (HAIs) and improve wound care outcomes
- For instance, in 2024, Smith+Nephew introduced an advanced antimicrobial wound dressing with patented silver technology that demonstrated improved infection control in post-operative wound care
- The growing preference for antimicrobial wound dressings is expected to boost market demand across hospitals, homecare, and outpatient settings
